The Michigan Anticoagulation Quality Improvement Initiative (MAQI2) found that patients taking warfarin in combination with aspirin had twice the rate of bleeding with no clear clinical benefit, similar to other published literature.
Spotlight On MyMichigan Health: Reducing Heart Failure Admissions After TAVR Procedures
MyMichigan Health experienced an increase in post-TAVR heart failure admissions in 2019 and 2020.
Site Spotlight - Trinity Health Ann Arbor
The Structural Heart Team at Trinity Health Ann Arbor realized that their pre-procedural baseline and 30-day KCCQ questionnaire documentation compliance was below the consortium’s average.
MISHC Meeting Summaries for Q4 2023
Did you miss a meeting or do you need a refresher? Read our Q4 2023 meeting summaries.
Staff Spotlight - Jeremy Albright, PhD
Jeremy Albright, PhD, is a MISHC Statistician conducting statistical analyses for peer-reviewed research manuscripts that utilize MISHC data.
New MiTVT2 Shared Decision Making Best Practice Protocol
Shared decision making is guideline-recommended for patients with valvular heart disease.
New Process for Report Distribution
The MISHC Coordinating Center will roll out a new process by which you will access your MISHC reports beginning with Q2 2023 reports.
New Best Practice Protocol - Post-TAVR Conduction System Abnormalities
A new Best Practice Protocol, “Post-TAVR Conduction System Abnormalities,” is now available on mishc.org.
MISHC Meeting Summaries for Q3 2023
Did you miss a meeting or do you need a refresher? Read our Q3 2023 meeting summaries.